Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inmune Bio (INMB) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Inmune Bio (INMB) over the last 4 years, with Q1 2025 value amounting to $166000.0.

  • Inmune Bio's Other Non Operating Income rose 217500.0% to $166000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $186340.0, marking a year-over-year increase of 51332.37%. This contributed to the annual value of $553000.0 for FY2024, which is 30711.61% up from last year.
  • As of Q1 2025, Inmune Bio's Other Non Operating Income stood at $166000.0, which was up 217500.0% from -$8000.0 recorded in Q1 2024.
  • Inmune Bio's 5-year Other Non Operating Income high stood at $166000.0 for Q1 2025, and its period low was -$8000.0 during Q1 2021.
  • For the 3-year period, Inmune Bio's Other Non Operating Income averaged around $50000.0, with its median value being -$8000.0 (2021).
  • The largest annual percentage gain for Inmune Bio's Other Non Operating Income in the last 5 years was 217500.0% (2025), contrasted with its biggest fall of 217500.0% (2025).
  • Inmune Bio's Other Non Operating Income (Quarter) stood at -$8000.0 in 2021, then changed by 0.0% to -$8000.0 in 2024, then soared by 2175.0% to $166000.0 in 2025.
  • Its Other Non Operating Income stands at $166000.0 for Q1 2025, versus -$8000.0 for Q1 2024 and -$8000.0 for Q1 2021.